尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Koenig Scott, 董事. Director active across 3 companies, notably Glycomimetics INC. Cumulatively, 13 disclosures have been published. Activity tracked since 18 May 2021. The latest transaction was disclosed on 15 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Koenig Scott is Director at Macrogenics INC, Glycomimetics INC, and Applied Genetic Technologies CORP. He has 13 filings in total, and among the sampled recent filings, the period runs from 2021-05-27 to 2026-02-17. Buy and sell amounts are 0, and the main recent filings concern Macrogenics INC and Glycomimetics INC, with amounts of 77048.06060949207, 24576.77447818735, and 11709.17996105598.